Xylocaine CAS: 137-58-6
Inquiry
| Post Date: | Aug 21,2015 |
| Expiry Date: | Feb 17,2016 |
| Detailed Description: |
Xylocaine CAS: 137-58-6
email:jaymee at ycphar dot com. Synonyms: 2', 6'-Acetoxylidide, 2-(diethylamino)- (8CI); 2-(Diethylamino)-N-(2, 6-dimethylphenyl)acetamide; Antrolin; Cuivasil; Dalcaine; ELA-Max; Esracaine; Isicaine; Jetocaine; Leostesin; Lidocadren; Lidoderm; Linisol; Maricaine; Penles; Remicaine; Solarcaine; Solcain; Xilina; Xycaine; Xyline; Xylocaine; Xylocitin; A-Diethylamino-2, 6-acetoxylidide; CAS No.: 137-58-6 EINECS: 205-302-8 Molecular Formula: C14H22N2O Molecular Weight: 234.34 g/mol Density: 1.026 g/cm3 Melting Point: 66-69 ° C Boiling Point: 350.8 ° C at 760 mmHg Flash Point: 166 ° C Application: It is a common local anesthetic and antiarrhythmic drug. Solubility: Soluble in water 2. Product Description: Lidocaine, xylocaine, or lignocaine is a common local anesthetic and class-1b antiarrhythmic drug. Lidocaine is used topically to relieve itching, burning, and pain from skin inflammations, injected as a dental anesthetic, or as a local anesthetic for minor surgery. It is on the World Health Organization's List of Essential Medicines, a list of the most important medications needed in a basic healthcare system. Lidocaine is the most important class-1b antiarrhythmic drug; It is used intravenously for the treatment of ventricular arrhythmias (for acute myocardial infarction, digoxin poisoning, cardioversion, or cardiac catheterization) if amiodarone is not available or contraindicated. Lidocaine should be given for this indication after defibrillation, CPR, and vasopressors have been initiated. A routine prophylactic administration is no longer recommended for acute cardiac infarction; The overall benefit of this measure is not convincing. 3. Application: The efficacy profile of lidocaine as a local anesthetic is characterized by a rapid onset of action and intermediate duration of efficacy. Therefore, lidocaine is suitable for infiltration, block, and surface anesthesia. Longer-acting substances such as bupivacaine are sometimes given preference for subdural and epidural anesthesias; Lidocaine, though, has the advantage of a rapid onset of action. Epinephrine vasoconstricts arteries, reducing bleeding and also delays the resorption of lidocaine, almost doubling the duration of anaesthesia. For surface anesthesia, several available formulations can be used e. G. For endoscopies, before intubations, etc. Buffering the pH of lidocaine makes local freezing less painful. [2] Lidocaine drops can be used on the eyes for short ophthalmic procedures. Relative insensitivity to lidocaine is genetic. In hypokalemic sensory overstimulation, relative insensitivity to lidocaine has been described in people who also have attention deficit hyperactivity disorder. In dental anesthesia, a relative insensitivity to lidocaine can occur for anatomical reasons due to unexpected positions of nerves. Some people with Ehlers-Danlos syndrome are insensitive to lidocaine. |
| Company: | Hubei Yuancheng Saichuang Technology Co., Ltd [ China ] |
| Contact: | laukenny |
| Tel: | 86-027-50756221 |
| Fax: | 86-027-68886696 |
| Email: | jaymee@ycphar.com |
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
